Search clinical trials for: Anti-HER2 Antibody Drug Conjugate (ADC)
Total 260771 results
-
Peking University Third HospitalRecruitingProliferative Diabetic RetinopathyChina
-
RemeGen Co., Ltd.RecruitingMuscle Invasive Bladder CarcinomaChina
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterADC TherapeuticsWithdrawnRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent High... and other conditionsUnited States
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Northwestern UniversityCompleted
-
ART Fertility Clinics LLCCompletedAnti-Mullerian Hormone IsoformsUnited Arab Emirates
-
ART Fertility Clinics LLCCompletedAnti-Mullerian Hormone ResistanceUnited Arab Emirates
-
Shanghai Miracogen Inc.RecruitingRelapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)China
-
Hannover Medical SchoolRecruitingLung Transplantation | Donor-specific Anti-human Leukocyte Antigen(HLA) AntibodiesGermany
-
Ottawa Hospital Research InstituteCompletedAged | Length of Stay | Epidemiology | Surgical Procedure, Operative | Anti CholinergicsCanada
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Australia, Korea, Republic of, United Kingdom
-
National Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | HER2/Neu PositiveUnited States, Puerto Rico
-
CONRADUnited States Agency for International Development (USAID); Agility Clinical...CompletedContraceptive Usage | Anti-Infective Agents | Anti-Retroviral AgentsDominican Republic, United States
-
Samsung Medical CenterUnknownOvarian Reserve | Gynecologic Operations | Anti-Mullerian Hormone
-
Isfahan University of Medical SciencesRecruiting
-
Karolinska University HospitalRecruitingBreast Cancer | Esophageal Neoplasms | HER2-positive Gastric Cancer | Gastric Neoplasms MalignantSweden
-
Alligator Bioscience ABCompleted
-
Johns Hopkins Bloomberg School of Public HealthUnited States Department of Defense; Naval Medical Research CenterCompleted
-
GenmabAbbVieTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B-cell LymphomaUnited States, Spain, Netherlands, Belgium, France, Denmark
-
xuexin heNot yet recruitingHER2-positive Breast Cancer
-
Beckman Coulter, Inc.Completed
-
Washington University School of MedicineWithdrawn
-
Poznan University of Medical SciencesUniversity at Buffalo; The Greater Poland Cancer CentreActive, not recruitingPopulation Modeling of Anti-infective DrugsPoland
-
Mårten SegelmarkHansa Biopharma ABCompletedAnti-Glomerular Basement Membrane Antibody DiseaseAustria, Czechia, Denmark, France, Sweden
-
Hospices Civils de LyonUnknown
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer HospitalRecruitingMuscle Invasive Bladder CarcinomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Peking UniversityRecruitingHER2 Positive Advanced Gastric CancerChina
-
Memorial Sloan Kettering Cancer CenterPfizerCompleted
-
Peking University Cancer Hospital & InstituteRecruiting
-
BayerCorporación Bonima S.A. de C.V.CompletedAnti-Infective AgentsMexico
-
Tianjin Medical University Second HospitalRecruiting
-
RemeGen Co., Ltd.Recruiting
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IIIA Hodgkin Lymphoma | Ann Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann... and other conditionsUnited States
-
Assiut UniversityNot yet recruitingAntiarrhythmic Toxicity
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC v8 | Prognostic Stage IIB Breast Cancer... and other conditionsUnited States, Puerto Rico
-
BeiGeneActive, not recruitingBreast Cancer | Gastric Cancer | Gastroesophageal Junction CancerChina, Taiwan, Korea, Republic of
-
Beckman Coulter, Inc.Not yet recruiting
-
Progenics Pharmaceuticals, Inc.Completed
-
Medical University of GrazTerminatedAnti-SARS-CoV-2 Antibody ResponseAustria
-
BayerCorporación Bonima S.A. de C.V.CompletedAnti-Infective AgentsMexico
-
Novartis PharmaceuticalsTerminatedPhase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid LeukemiaAML | cKIT-positive Solid TumorsBelgium, Spain, Australia, Netherlands
-
RemeGen Co., Ltd.Recruiting
-
Shanghai Institute Of Biological ProductsShanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruiting
-
ANRS, Emerging Infectious DiseasesCompleted
-
Huabo Biopharm Co., Ltd.Recruiting
-
Baxalta now part of ShireTerminatedSystemic Lupus ErythematosusAustralia, United States, New Zealand, Mexico, Canada